A Physiologically Based Pharmacokinetic Framework for Quantifying Antibody Distribution Gradients from Tumors to Tumor-Draining Lymph Nodes

Immune checkpoint blockades prescribed in the neoadjuvant setting are now under active investigation for many types of tumors, and many have shown early success. The primary tumor (PT) and tumor-draining lymph node (TDLN) immune factors, along with adequate therapeutic antibody distributions to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado, Eric, Cao, Yanguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036243/
https://www.ncbi.nlm.nih.gov/pubmed/35466281
http://dx.doi.org/10.3390/antib11020028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036243/
https://www.ncbi.nlm.nih.gov/pubmed/35466281
http://dx.doi.org/10.3390/antib11020028

Ejemplares similares